Pavan Oagwin Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 1 Year 1 Month
- Last Filing with ROC 31 Mar 2024
About Pavan Oagwin Pharmaceuticals
Pavan Oagwin Pharmaceuticals Private Limited (POPPL) is a Private Limited Indian Non-Government Company incorporated in India on 11 January 2024 (One year and one month 11 days old ). Its registered office is in Hyderabad, Telangana, India.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Thatisetti Kumar, Bolla Divya, Venu Davuluri, and Two other members serve as directors at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U46497TS2024PTC180944
- Company No.
180944
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Jan 2024
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Who are the key members and board of directors at Pavan Oagwin Pharmaceuticals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Thatisetti Kumar  | Managing Director | 11-Jan-2024 | Current |
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Bolla Divya | Director | 11-Jan-2024 | Current |
| Venu Davuluri | Director | 11-Jan-2024 | Current |
| Sadikha Shaik | Director | 11-Jan-2024 | Current |
| Swetha Thatisetti | Director | 11-Jan-2024 | Current |
Financial Performance of Pavan Oagwin Pharmaceuticals.
Enhance accessibility to Pavan Oagwin Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Pavan Oagwin Pharmaceuticals?
Unlock access to Pavan Oagwin Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Oagwin Pharmaceuticals Private LimitedThatisetti Kumar, Bolla Divya and 3 more are mutual person
- Nev Engineering Consultants Private Limited
Venu Davuluri is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Pavan Oagwin Pharmaceuticals?
Unlock and access historical data on people associated with Pavan Oagwin Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pavan Oagwin Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pavan Oagwin Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.